Suppr超能文献

一种新型血管内膜氧合器,用于增强急性呼吸衰竭患者的血气交换。

A new intravascular membrane oxygenator to augment blood gas transfer in patients with acute respiratory failure.

作者信息

Zwischenberger J B, Cox C S

机构信息

University of Texas Medical Branch, Galveston.

出版信息

Tex Med. 1991 Dec;87(12):60-3.

PMID:1801294
Abstract

The IVOX (intravascular oxygenator) is an intracorporeal, hollow-fibre membrane oxygenator and carbon dioxide (CO2) removal device. The IVOX is surgically placed into the vena cava via a femoral or jugular venotomy. Oxygen (O2) is pulled through the hollow fibers by a vacuum pump controlled by a flow meter. There is no extracorporeal circulation of blood. Gas exchange occurs as the patient's blood flows over several hundred hollow fibers. Inlet and outlet gas conduits exit a small skin incision for inflow of O2 and outflow of CO2. Studies in sheep and humans show that the IVOX can support approximately 30% of gas exchange requirements. The position of the IVOX in the vena cava does not affect hemodynamics or cause thromboembolic complications. It can remain in place for up to 22 days without affecting hematologic or blood chemistry parameters. The IVOX is currently undergoing clinical trials at selected medical centers in patients with acute respiratory failure.

摘要

血管内氧合器(IVOX)是一种体内中空纤维膜式氧合器及二氧化碳(CO2)清除装置。IVOX通过股静脉切开术或颈静脉切开术经手术放置于腔静脉内。氧气(O2)由流量计控制的真空泵经中空纤维抽出。不存在体外血液循环。当患者血液流经数百根中空纤维时发生气体交换。进出气导管经一个小的皮肤切口穿出,用于氧气的流入和二氧化碳的流出。在绵羊和人体上进行的研究表明,IVOX可满足约30%的气体交换需求。IVOX在腔静脉内的位置不影响血流动力学,也不会引起血栓栓塞并发症。它可在体内留置长达22天而不影响血液学或血液化学参数。目前IVOX正在部分医疗中心对急性呼吸衰竭患者进行临床试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验